IOL CHEMICALS & PHARM. | MERCURY LAB. | IOL CHEMICALS & PHARM./ MERCURY LAB. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.6 | 25.0 | 54.4% | View Chart |
P/BV | x | 1.5 | 2.3 | 68.7% | View Chart |
Dividend Yield | % | 1.0 | 0.4 | 246.4% |
IOL CHEMICALS & PHARM. MERCURY LAB. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
MERCURY LAB. Mar-23 |
IOL CHEMICALS & PHARM./ MERCURY LAB. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 1,000 | 53.7% | |
Low | Rs | 272 | 390 | 69.8% | |
Sales per share (Unadj.) | Rs | 377.6 | 627.8 | 60.2% | |
Earnings per share (Unadj.) | Rs | 23.7 | 46.5 | 51.0% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 67.2 | 47.0% | |
Dividends per share (Unadj.) | Rs | 4.00 | 3.50 | 114.3% | |
Avg Dividend yield | % | 1.0 | 0.5 | 196.4% | |
Book value per share (Unadj.) | Rs | 256.8 | 380.2 | 67.5% | |
Shares outstanding (eoy) | m | 58.71 | 1.20 | 4,892.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.1 | 96.7% | |
Avg P/E ratio | x | 17.1 | 14.9 | 114.1% | |
P/CF ratio (eoy) | x | 12.8 | 10.3 | 123.9% | |
Price / Book Value ratio | x | 1.6 | 1.8 | 86.2% | |
Dividend payout | % | 16.9 | 7.5 | 224.2% | |
Avg Mkt Cap | Rs m | 23,743 | 834 | 2,846.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 139 | 1,209.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 753 | 2,943.0% | |
Other income | Rs m | 256 | 17 | 1,489.8% | |
Total revenues | Rs m | 22,427 | 771 | 2,910.6% | |
Gross profit | Rs m | 2,257 | 86 | 2,618.3% | |
Depreciation | Rs m | 462 | 25 | 1,859.0% | |
Interest | Rs m | 165 | 4 | 4,549.7% | |
Profit before tax | Rs m | 1,887 | 75 | 2,517.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 19 | 2,586.7% | |
Profit after tax | Rs m | 1,391 | 56 | 2,494.0% | |
Gross profit margin | % | 10.2 | 11.4 | 89.0% | |
Effective tax rate | % | 26.2 | 25.5 | 102.7% | |
Net profit margin | % | 6.3 | 7.4 | 84.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 417 | 2,317.6% | |
Current liabilities | Rs m | 5,025 | 164 | 3,058.9% | |
Net working cap to sales | % | 20.9 | 33.6 | 62.4% | |
Current ratio | x | 1.9 | 2.5 | 75.8% | |
Inventory Days | Days | 43 | 7 | 605.9% | |
Debtors Days | Days | 8 | 1,035 | 0.8% | |
Net fixed assets | Rs m | 11,017 | 259 | 4,259.2% | |
Share capital | Rs m | 587 | 12 | 4,892.5% | |
"Free" reserves | Rs m | 14,490 | 444 | 3,261.4% | |
Net worth | Rs m | 15,077 | 456 | 3,304.3% | |
Long term debt | Rs m | 0 | 24 | 0.0% | |
Total assets | Rs m | 20,684 | 676 | 3,060.9% | |
Interest coverage | x | 12.5 | 21.7 | 57.4% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 1.1 | 96.2% | |
Return on assets | % | 7.5 | 8.8 | 85.6% | |
Return on equity | % | 9.2 | 12.2 | 75.5% | |
Return on capital | % | 13.6 | 16.3 | 83.2% | |
Exports to sales | % | 26.7 | 25.3 | 105.6% | |
Imports to sales | % | 0 | 0.4 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 191 | 3,108.5% | |
Imports (cif) | Rs m | NA | 3 | 0.0% | |
Fx inflow | Rs m | 5,930 | 191 | 3,108.5% | |
Fx outflow | Rs m | 6,052 | 8 | 76,605.1% | |
Net fx | Rs m | -122 | 183 | -66.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 25 | 4,986.5% | |
From Investments | Rs m | -1,200 | -11 | 11,352.9% | |
From Financial Activity | Rs m | -41 | -10 | 405.7% | |
Net Cashflow | Rs m | -18 | 4 | -480.4% |
Indian Promoters | % | 48.2 | 73.7 | 65.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 26.3 | 196.7% | |
Shareholders | 130,003 | 1,214 | 10,708.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA ZYDUS LIFESCIENCES DR. REDDYS LAB
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | MERCURY LAB. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.26% | -1.94% | 0.50% |
1-Month | 5.36% | 3.81% | 2.59% |
1-Year | -3.00% | 37.27% | 56.21% |
3-Year CAGR | -12.99% | 5.44% | 15.23% |
5-Year CAGR | 16.73% | 24.23% | 19.64% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the MERCURY LAB. share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of MERCURY LAB. the stake stands at 73.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of MERCURY LAB..
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
MERCURY LAB. paid Rs 3.5, and its dividend payout ratio stood at 7.5%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of MERCURY LAB..
For a sector overview, read our pharmaceuticals sector report.
Asian shares rose cautiously on Friday as markets sobered up to the idea that U.S. rate cuts were most likely some time away.